Pseudogene-derived IKBKG gene mutations in incontinentia pigmenti

Clinical Genetics

Volumn 76, Issue 4, 2009, Pages 417-419

  Lee, N C ^a   Huang, C H ^b   Hwu, W L ^a   Chien, Y H ^a   Chang, Y Y ^b   Chen, C H ^b   Ko, T M ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b Genephile Bioscience Laboratory   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CYTOSINE; GLYCINE; I KAPPA B KINASE GAMMA;

BLOOD ANALYSIS; CHINESE; CHROMOSOME SEGREGATION; CLINICAL ARTICLE; EXON; FAMILY STUDY; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE MUTATION; GENETIC POLYMORPHISM; HETEROZYGOSITY; HUMAN; INCONTINENTIA PIGMENTI; LETTER; MALE; POINT MUTATION; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; PSEUDOGENE; TANDEM REPEAT; X CHROMOSOME;

ASIAN CONTINENTAL ANCESTRY GROUP; DNA PRIMERS; HUMANS; I-KAPPA B KINASE; INCONTINENTIA PIGMENTI; MUTATION; PEDIGREE; PHENOTYPE; PSEUDOGENES; TAIWAN;

EID: 70350147410     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2009.01232.x     Document Type: Letter

References (11)

1. Smahi A, Courtois G, Vabres P. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Nature 2000, 405(6785):466-472.
2. Aradhya S, Bardaro T, Galgoczy P. Multiple pathogenic and benign genomic rearrangements occur at a 35 kb duplication involving the NEMO and LAGE2 genes. Hum Mol Genet 2001, 10(22):2557-2567.
3. Aradhya S, Woffendin H, Jakins T. A recurrent deletion in the ubiquitously expressed NEMO (IKK-gamma) gene accounts for the vast majority of incontinentia pigmenti mutations. Hum Mol Genet 2001, 10(19):2171-2179.
4. Aradhya S, Courtois G, Rajkovic A. Atypical forms of incontinentia pigmenti in male individuals result from mutations of a cytosine tract in exon 10 of NEMO (IKK-gamma). Am J Hum Genet 2001, 68(3):765-771.
5. Fusco F, Bardaro T, Fimiani G. Molecular analysis of the genetic defect in a large cohort of IP patients and identification of novel NEMO mutations interfering with NF-kappaB activation. Hum Mol Genet 2004, 13(16):1763-1773.
6. Fusco F, Pescatore A, Bal E. Alterations of the IKBKG locus and diseases: an update and a report of 13 novel mutations. Human Mutation 2008, 29(5):595-604.
7. Bardaro T, Falco G, Sparago A. Two cases of misinterpretation of molecular results in incontinentia pigmenti, and a PCR-based method to discriminate NEMO/IKKgamma dene deletion. Hum Mutat 2003, 21(1):8-11.
8. Hwa HL, Chang YY, Lee JC. Thirteen X-chromosomal short tandem repeat loci multiplex data from Taiwanese. Int J Legal Med 2009, 123(3):263-269.
9. Brown JT, Lahey C, Laosinchai-Wolf W. Polymorphisms in the glucocerebrosidase gene and pseudogene urge caution in clinical analysis of Gaucher disease allele c.1448T >C (L444P). BMC Med Genet 2006, 7:69.
10. Araujo RS, Mendonca BB, Barbosa AS. Microconversion between CYP21A2 and CYP21A1P promoter regions causes the nonclassical form of 21-hydroxylase deficiency. J Clin Endocrinol Metab 2007, 92(10):4028-4034.
11. Zou CC, Zhao ZY. Clinical and molecular analysis of NF-kappaB essential modulator in Chinese incontinentia pigmenti patients. Int J Dermatol 2007, 46(10):1017-1022.